Insights

Gathering insights about Emerge…

Similar companies to Emerge

Emerge Tech Stack

Emerge uses 8 technology products and services including Tableau, Fastly, WordPress, and more. Explore Emerge's tech stack below.

Tableau
Business Intelligence
Fastly
Content Delivery Network
WordPress
Content Management System
Figma
Design
Selenium
Frameworks And Libraries
Zendesk Sunshine Conversations
Live Chat
Amazon ALB
Load Balancers
Marketo
Marketing Automation

Media & News

Emergent BioSolutions Reports First Quarter 2026 Financial Results
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the first quarter ended March 31, 2026.
Apr 30, 2026 | www.globenewswire.com
Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox
GAITHERSBURG, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Singapore's Health Sciences Authority (HSA) has approved an expanded indication for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to include prevention of mpox disease in adults determined to be at high risk for mpox infection.
Apr 30, 2026 | www.globenewswire.com
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
GAITHERSBURG, Md., April 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS, SAB BIO) to support the process development and manufacturing of SAB-142, SAB BIO's lead program in clinical development for autoimmune type 1 diabetes (T1D). The executed agreement is valued at approximately $50 million, of which $36 million is contingent on future regulatory approval and downstream milestones.
Apr 29, 2026 | www.globenewswire.com
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
WINNIPEG, Manitoba, April 29, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE: EBS) announced it is teaming up with professional baseball player Davis Schneider to break down the stigma around opioid poisonings and educate the public on how to be prepared to help save a life with NARCAN® Nasal Spray. Schneider, who unexpectedly lost his brother Steven in 2020, shares his family's story as part of Emergent's Opioid Crisis Impact Map, an interactive platform that highlights lived experiences from across the country and illustrates the devastating toll of the opioid crisis.
Apr 29, 2026 | www.globenewswire.com
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has entered into an agreement with Substipharm Biologics valued at approximately $34.5 million to support drug substance manufacturing for its Japanese Encephalitis (JE) vaccine, licensed internationally under the brand name IMOJEV® at Emergent's Canton, Massachusetts facility, and for Emergent to serve as the exclusive distributor of the vaccine to the U.S. government, following potential U.S. Food & Drug Administration (FDA) regulatory endeavors.
Apr 28, 2026 | www.globenewswire.com
Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS
The April/May 2026 Ben Graham All-Star Value Dogs list highlights 14 'safer,' fair-priced large-cap value stocks with robust, reliable dividends. Analyst forecasts project average net gains of 39.88% by April/May 2027 for the top ten yielding GASV stocks, with risk profiles generally below market average. Dividend safety is emphasized: 27 of 71 GASV names are 'safer' by free cash flow, but only 14 are both 'safer' and fairly priced for immediate purchase.
Apr 24, 2026 | seekingalpha.com
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2026, at 5:00 p.m.
Apr 16, 2026 | www.globenewswire.com

Emerge's Email Address Formats

Emerge uses at least 3 format(s):

Emerge Email Formats	Example	Percentage
FirstL@emergecenter.org	JohnD@emergecenter.org	67%
FL@emergecenter.org	JD@emergecenter.org	16%
Last@emergecenter.org	Doe@emergecenter.org	9%
L.First@emergecenter.org	D.John@emergecenter.org	8%
FLast@emergetms.com	JDoe@emergetms.com	98%
FMLast@emergetms.com	JMDoe@emergetms.com	2%
FLast@emergemarket.com	JDoe@emergemarket.com	90%
Last@emergemarket.com	Doe@emergemarket.com	9%
First@emergemarket.com	John@emergemarket.com	1%

Frequently Asked Questions

Where is Emerge's headquarters located?

Emerge's main headquarters is located at 9055 East Del Camino Drive Scottsdale, Arizona 85258 United States. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is Emerge's phone number?

You can contact Emerge's main corporate office by phone at

+1-520-573-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Emerge's stock symbol?

Emerge is a publicly traded company; the company's stock symbol is EBS.

What is Emerge's official website and social media links?

Emerge's official website is emergemarket.com and has social profiles on LinkedIn.

What is Emerge's NAICS code?

Emerge's NAICS code is 5112 - Software Publishers.

How many employees does Emerge have currently?

As of April 2026, Emerge has approximately 223 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Technology Officer: K. J.Chief Financial Officer: B. B.Chief Technology Officer: B. S.. Explore Emerge's employee directory with LeadIQ.

What industry does Emerge belong to?

Emerge operates in the Software Development industry.

What technology does Emerge use?

Emerge's tech stack includes TableauFastlyWordPressFigmaSeleniumZendesk Sunshine ConversationsAmazon ALBMarketo.

What is Emerge's email format?

Emerge's email format typically follows the pattern of FirstL@emergecenter.org. Find more Emerge email formats with LeadIQ.

When was Emerge founded?

Emerge was founded in 2017.

Emerge

Q: What is Emerge's official website and social media links?

Emerge's official website is emergemarket.com. Emerge has social profiles on LinkedIn.

Q: How many employees does Emerge have currently?

Emerge has approximately 223 employees.

Q: What technology does Emerge use?

Emerge's tech stack includes HubSpot Analytics, jsDelivr, Google Sign-in, LinkedIn Ads, HubSpot.

Q: What is Emerge's NAICS code?

Emerge's NAICS code is 5112 (Software Publishers).

Software DevelopmentArizona, United States201-500 Employees

Emerge is a leading technology provider with its revolutionary Freight Procurement Platform. Emerge offers solutions that enhance the procurement process for spot and contract freight by providing current benchmarking data, real-time connectivity, and data-driven insights enabling shippers and carriers to make more empowered strategic decisions. Backed by a marketplace of 45k+ quality carriers and its Premier Carrier Program, shippers can expand their network with confidence.

Founded in 2017, and located in Scottsdale, Arizona, and Atlanta, Georgia, Emerge is one of the fastest-growing technology startups in the U.S and we are recognized as the #23 best startup employer in the US by Forbes in 2021!

Company Overview

Headquarters: 9055 East Del Camino Drive Scottsdale, Arizona 85258 United States
Phone number: +1-520-573-****
Website: emergemarket.com
Stock Symbol: EBS
NAICS Code: 5112 - Software Publishers
Founded: 2017
Employees: 201-500

Media & News

Funding & Financials

$100M$250M
Emerge's revenue is estimated to be in the range of $100M$250M

Funding & Financials

$100M$250M
Emerge's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Emerge

Zycus

SAP

Coupa

Proactis

Tradeshift

Basware

Ivalua

JAGGAER

BirchStreet Systems

Oracle

Emerge Tech Stack

Media & News

Emergent BioSolutions Reports First Quarter 2026 Financial Results

Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox

Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives

Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States

Buy 14 Ideal Graham Value All-Stars Of 27 'Safer' Dividends In 71 April/May GVAS

Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026

Emerge's Email Address Formats

Frequently Asked Questions

Where is Emerge's headquarters located?

What is Emerge's phone number?

What is Emerge's stock symbol?

What is Emerge's official website and social media links?

What is Emerge's NAICS code?

How many employees does Emerge have currently?

What industry does Emerge belong to?

What technology does Emerge use?

What is Emerge's email format?

When was Emerge founded?

Emerge

Company Overview

Media & News

Emergent BioSolutions Reports First Quarter 2026 Financial Results

Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox

Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?